Translational medicine, a subset of translational science, focuses on applying fundamental biomedical research to clinical practice. Its purpose is to convert basic scientific discoveries into practical medical applications. According to the European Society for Translational Medicine, it is an interdisciplinary field structured around three core components: benchside (laboratory research), bedside (clinical application), and community (public health impact). The main objective of translational medicine is to integrate knowledge, methodologies, and resources across these components to advance disease prevention, diagnosis, and treatment. By effectively coordinating these elements, translational medicine aims to enhance healthcare outcomes and improve the overall healthcare system.
Translational medicine focuses on converting promising laboratory discoveries into clinical applications and addressing clinical questions to enhance prediction, prevention, diagnosis, and treatment of diseases. Translational research advances basic academic findings into applied research, ideally creating a seamless continuum between academic investigation and development in collaboration with relevant stakeholders, with a clear patient-centered goal. These goals may include optimized treatment protocols, novel therapeutics, or innovative diagnostics with measurable outcomes, such as improved quality of life. In this way, translational medicine applies fundamental medical biology discoveries in practice, employing new technologies and methodologies to bridge laboratory research and clinical implementation.
Actively involving patients as key stakeholders ensures that translational strategies address unmet clinical needs and generate solutions tailored to real-world patient priorities, improving outcomes and enhancing quality of life.
The term translational medicine emerged in the 1990s but became widely adopted in the early 2000s. Initially, translational medical research developed from the bench-to-bedside (B2B) concept, aiming to remove the barriers between laboratory and clinical research, which traditionally operated in isolation. Over time, translational medicine evolved into an interdisciplinary field through integration of knowledge from clinical pharmacology, cell biology, genetics, chemistry, physiology, and other disciplines. Its formal establishment also required incorporating process-oriented and organizational elements, enabling coordinated collaboration to transform research discoveries into practical solutions for patients.
In 2003, the Institute of Medicine Clinical Research Roundtable described translational research as a two-phase process progressing from:
- Basic science to clinical science
- Clinical science to public health impact
Subsequent refinements led to the “4T” model of translational research:
- T1: Translation of basic scientific discoveries (basic knowledge) into potential clinical applications (theoretical knowledge)
- T2: Development of evidence-based guidelines (efficacy knowledge)
- T3: Implementation of clinical care or interventions (applied knowledge)
- T4: Assessment of population or community health outcomes (public health knowledge)
In 2017, a preliminary phase, T0, was proposed to include genome-wide association studies and other foundational research feeding back into T1.
Rather than discrete stages, translational medicine is viewed as a continuum, where each stage informs and builds upon the others. According to the NIH National Center for Advancing Translational Sciences (NCATS), the spectrum spans from understanding the biological basis of health and disease to developing interventions that improve individual and public health. All stages require method development, demonstration of effectiveness, and dissemination of results. Patient engagement remains a critical component across this continuum.
Monash University highlights that clinical research and translational medicine occupy a central role in connecting the various disciplines within this translational continuum.
Exemple of : progress in the treatment of cancer with the recent advances in the discovery and development of cancer immunotherapies.
Translational medicine operates as a bi-directional process, facilitating the flow of knowledge and hypotheses between laboratory research and clinical practice. This includes:
Bedside-to-bench
Using clinical observations to inform laboratory research, generate new hypotheses, and refine diagnostics, therapies, and preventive measures. Real-world data and evidence further enhance this process, enabling the development of improved solutions. For instance, the detection of auto-antibodies in patients with specific diseases can inform new patient stratification strategies and support the development of more effective treatments.
Bench-to-bedside
Accelerating the clinical evaluation of novel therapeutic strategies derived from laboratory research.